Literature DB >> 7104545

A new clinical scale for the staging of dementia.

C P Hughes, L Berg, W L Danziger, L A Coben, R L Martin.   

Abstract

Accurate clinical staging of dementia in older subjects has not previously been achieved despite the use of such methods as psychometric testing, behavioural rating, and various combinations of simpler psychometric and behavioural evaluations. The Clinical Dementia Rating (CRD), a global rating device, was developed for a prospective study of mild senile dementia--Alzheimer type (SDAT). Reliability, validity, and correlational data are discussed. The CRD was found to distinguish unambiguously among older subjects with a wide range of cognitive function, from healthy to severely impaired.

Entities:  

Mesh:

Year:  1982        PMID: 7104545     DOI: 10.1192/bjp.140.6.566

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  1508 in total

1.  A single-photon emission computed tomography imaging study of driving impairment in patients with Alzheimer's disease.

Authors:  B R Ott; W C Heindel; W M Whelihan; M D Caron; A L Piatt; R B Noto
Journal:  Dement Geriatr Cogn Disord       Date:  2000 May-Jun       Impact factor: 2.959

Review 2.  The impact of mild cognitive impairment on functional abilities in the elderly.

Authors:  Steven M Albert; Matias H Tabert; Alan Dienstag; Gregory Pelton; Devangere Devanand
Journal:  Curr Psychiatry Rep       Date:  2002-02       Impact factor: 5.285

3.  Influence of leisure activity on the incidence of Alzheimer's disease.

Authors:  N Scarmeas; G Levy; M X Tang; J Manly; Y Stern
Journal:  Neurology       Date:  2001-12-26       Impact factor: 9.910

4.  Detection of grey matter loss in mild Alzheimer's disease with voxel based morphometry.

Authors:  G B Frisoni; C Testa; A Zorzan; F Sabattoli; A Beltramello; H Soininen; M P Laakso
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-12       Impact factor: 10.154

5.  Latent classes of course in Alzheimer's disease and predictors: the Cache County Dementia Progression Study.

Authors:  Jeannie-Marie S Leoutsakos; Sarah N Forrester; Christopher D Corcoran; Maria C Norton; Peter V Rabins; Martin I Steinberg; Joann T Tschanz; Constantine G Lyketsos
Journal:  Int J Geriatr Psychiatry       Date:  2014-11-03       Impact factor: 3.485

6.  Adjuvant transcranial direct current stimulation for treating Alzheimer's disease: A case study.

Authors:  Suellen Marinho Andrade; Camila Teresa Ponce Leon de Mendonça; Thobias Cavalcanti Laurindo Pereira; Bernardino Fernandez-Calvo; Regina Coely Neves Araújo; Nelson Torro Alves
Journal:  Dement Neuropsychol       Date:  2016 Apr-Jun

7.  Automated 3D mapping of hippocampal atrophy and its clinical correlates in 400 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls.

Authors:  Jonathan H Morra; Zhuowen Tu; Liana G Apostolova; Amity E Green; Christina Avedissian; Sarah K Madsen; Neelroop Parikshak; Xue Hua; Arthur W Toga; Clifford R Jack; Norbert Schuff; Michael W Weiner; Paul M Thompson
Journal:  Hum Brain Mapp       Date:  2009-09       Impact factor: 5.038

8.  Differing patterns of psychiatric impairment in Alzheimer and demented parkinsonian patients.

Authors:  P Soliveri; M B Zappacosta; L Austoni; P Caffarra; A Scaglioni; D Testa; E Palazzini; T Caraceni; F Girotti
Journal:  Ital J Neurol Sci       Date:  1994-11

9.  Further analysis of the cognitive effects of tetrahydroaminoacridine (THA) in Alzheimer's disease: assessment of attentional and mnemonic function using CANTAB.

Authors:  B J Sahakian; A M Owen; N J Morant; S A Eagger; S Boddington; L Crayton; H A Crockford; M Crooks; K Hill; R Levy
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

10.  "Everything hurts!" Distress in semantic variant primary progressive aphasia.

Authors:  Megan S Barker; Hannah E Silverman; Rachel Fremont; Masood Manoochehri; Stephanie Cosentino; Edward D Huey
Journal:  Cortex       Date:  2020-03-24       Impact factor: 4.027

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.